Benefits of using heterologous polyclonal antibodies and potential application to new and undertreated infectious pathogens.

CONCLUSIONS: Polyclonal antibodies have been successfully applied to rabies, envenomation and intoxication. Polyclonal production provides an exciting opportunity to revolutionise the prognosis of both longstanding neglected tropical diseases as well as emerging infectious threats to humans. PMID: 26802604 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26802604?dopt=Abstract

Source: Vaccine - January 20, 2016 Category: Allergy & Immunology Authors: Dixit R, Herz J, Dalton R, Booy R Tags: Vaccine Source Type: research